AI assistant
Sending…
MAYNE PHARMA GROUP LIMITED — Capital/Financing Update 2007
Jun 26, 2007
65396_rns_2007-06-26_7d9cf211-f3da-4c09-81f3-cf9062831c70.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer

MARKET RELEASE
27 June 2007
HalcyGen Pharmaceuticals Limited
ADMISSION TO OFFICIAL LIST
HalcyGen Pharmaceuticals Limited was admitted to the Official List of ASX Limited on Wednesday, 27 June 2007.
Official Quotation of the following securities will commence at 11.00 am E.S.T. on Friday, 29 June 2007.
34,421,200
ordinary shares fully paid
25,000,000 ordinary shares fully paid were issued under the prospectus dated 23 May 2007, with an issue price of 50 cents each.
Security Code: HGN
Kate Kidson Senior Adviser, Issuers
More from MAYNE PHARMA GROUP LIMITED
Director's Dealing
2026
Jun 5
Legal Proceedings Report
2026
Jun 5
Investor Presentation
2026
Jun 4
Regulatory Filings
2026
Jun 1
Report Publication Announcement
2026
May 26
Legal Proceedings Report
2026
May 21
Regulatory Filings
2026
May 17
Investor Presentation
2026
May 6
Regulatory Filings
2026
May 3
Remuneration Information
2026
Apr 29